Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism QPCTL inhibitors(glutaminyl-peptide cyclotransferase like inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 25 Apr 2024 | |
B-Cell Lymphoma | Phase 1 | CN | 25 Apr 2024 | |
B-cell lymphoma recurrent | Phase 1 | CN | 11 Apr 2024 | |
B-cell lymphoma refractory | Phase 1 | CN | 11 Apr 2024 | |
Solid tumor | Phase 1 | CN | 11 Apr 2024 |